Bill & Melinda Gates FoundationGlobal Grand Challenges
  • Grant Opportunities
  • Challenges
  • Awards
  • Champions
  • Partnerships
  • News
  • About

A New Tool for Anti-Malarial Target Gene Validation

Philip J. Shaw of Thailand's National Center for Genetic Engineering and Biotechnology will seek to identify potential drug targets and vaccine antigens in the malaria parasite using a novel technology to reduce specific gene expression. By fusing a natural genetic "riboswitch" onto gene targets, the team will attempt to attenuate gene expression and thereby determine gene function.

More information about Create New Tools to Accelerate the Eradication of Malaria (Round 3)